AU6077599A - Method for improving the gene transfer of genetic material in mammalian cells through the use of p21 (waf-1) - Google Patents

Method for improving the gene transfer of genetic material in mammalian cells through the use of p21 (waf-1)

Info

Publication number
AU6077599A
AU6077599A AU60775/99A AU6077599A AU6077599A AU 6077599 A AU6077599 A AU 6077599A AU 60775/99 A AU60775/99 A AU 60775/99A AU 6077599 A AU6077599 A AU 6077599A AU 6077599 A AU6077599 A AU 6077599A
Authority
AU
Australia
Prior art keywords
improving
mammalian cells
genetic material
gene transfer
waf
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU60775/99A
Inventor
Bernd Dorken
Axel Schumacher
Gerhard Wolff
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Max Delbrueck Centrum fuer Molekulare in der Helmholtz Gemeinschaft
Original Assignee
Max Delbrueck Centrum fuer Molekulare in der Helmholtz Gemeinschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Max Delbrueck Centrum fuer Molekulare in der Helmholtz Gemeinschaft filed Critical Max Delbrueck Centrum fuer Molekulare in der Helmholtz Gemeinschaft
Publication of AU6077599A publication Critical patent/AU6077599A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4738—Cell cycle regulated proteins, e.g. cyclin, CDC, INK-CCR
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10341—Use of virus, viral particle or viral elements as a vector
    • C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Virology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

The invention relates to a method for stabilizing and improving the gene transfer of genetic material in mammalian cells, characterized in that the gene or its cDNA is expressed in the target cell with simultaneous expression of the cell cycle regulator p21, which prevents apoptosis.
AU60775/99A 1998-07-10 1999-07-12 Method for improving the gene transfer of genetic material in mammalian cells through the use of p21 (waf-1) Abandoned AU6077599A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19830874A DE19830874A1 (en) 1998-07-10 1998-07-10 Process for stabilizing and improving gene transfer from genetic material in mammalian cells
DE19830874 1998-07-10
PCT/DE1999/002180 WO2000003027A1 (en) 1998-07-10 1999-07-12 Method for improving the gene transfer of genetic material in mammalian cells through the use of p21 (waf-1)

Publications (1)

Publication Number Publication Date
AU6077599A true AU6077599A (en) 2000-02-01

Family

ID=7873575

Family Applications (1)

Application Number Title Priority Date Filing Date
AU60775/99A Abandoned AU6077599A (en) 1998-07-10 1999-07-12 Method for improving the gene transfer of genetic material in mammalian cells through the use of p21 (waf-1)

Country Status (5)

Country Link
EP (1) EP1097234B1 (en)
AT (1) ATE292688T1 (en)
AU (1) AU6077599A (en)
DE (2) DE19830874A1 (en)
WO (1) WO2000003027A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19954444A1 (en) * 1999-11-11 2001-05-31 Theragen Molekularmedizinische Method of protecting mammalian cells using overexpressed G-2 / M cell cycle couplers
DE10015413A1 (en) * 2000-03-23 2001-09-27 Max Delbrueck Centrum Composition for treating and diagnosing viral infections, caused by adenovirus, comprises an agent that modifies function of YB-1 protein, and YB-1 specific antibodies
GB0113318D0 (en) * 2001-06-01 2001-07-25 Lonza Biologics Plc Method for production of a protein

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5863904A (en) * 1995-09-26 1999-01-26 The University Of Michigan Methods for treating cancers and restenosis with P21

Also Published As

Publication number Publication date
EP1097234A1 (en) 2001-05-09
DE19830874A1 (en) 2000-01-13
EP1097234B1 (en) 2005-04-06
ATE292688T1 (en) 2005-04-15
DE59911877D1 (en) 2005-05-12
WO2000003027A1 (en) 2000-01-20

Similar Documents

Publication Publication Date Title
AU560340B2 (en) Rennin from recombinant dna
WO1998020145A3 (en) Improvements in or relating to starch content of plants
MX9606476A (en) The cytoplasmic inhibition of gene expression.
MX9705039A (en) Programmed cell death genes and proteins.
AU6131086A (en) Epithelial cells expressing foreign genetic material
AU4336499A (en) Regulation of hematopoietic stem cell differentiation by the use of human mesenchymal stem cells
BR0012099A (en) Cytoplasmic transfer to de-differentiate recipient cells
WO2001051616A3 (en) Techniques for growth and differentiation of human pluripotent stem cells
MX9800719A (en) Transport proteins and their uses.
HK1091228A1 (en) Methods for making recombinant proteins using apoptosis inhibitors
ES2255281T3 (en) OVEREXPRESSION OF FITASA GENES IN SISTMAS DE LEVADURA.
MX9800499A (en) Inhibition of gene expression.
IL117425A0 (en) Receptor activation by gas6
BR9712942A (en) Method for the production of glycerol, transformed host cell, method for the selection of gene expression, strain pah21 / dh5x of escherichia coli and strain pah21 / dh5x of escherichia coli.
MX9800500A (en) Inhibition of gene expression.
CA2250693A1 (en) Compositions and methods for taxol biosynthesis
WO1998037185A3 (en) Vectors for controlled gene expression
AU2422299A (en) Culture device and method for cultivating cells or tissue components
AU6077599A (en) Method for improving the gene transfer of genetic material in mammalian cells through the use of p21 (waf-1)
AUPN896596A0 (en) Therapeutic molecules
EP0808364A4 (en) Human pancreatic cell lines: developments and uses
DE69515652D1 (en) USE OF DNA OLIGOMERS TO INHIBIT HIV BY REDUCING RIBOSOMAL READER COATING
WO1996009399A3 (en) Chimeric adenovirus for gene delivery
WO2000006713A3 (en) Methods for recombinant protein production in mammalian cells comprising co-expression with fetuin
AU7529000A (en) Method for identifying novel genes involved in the regulation of angiogenesis, study of said genes and use thereof for therapeutic purposes

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase